Changes of plasma nitric oxide, endothelin-1, and blood coagulation following intravitreal conbercept

Intravitreal anti-VEGF (anti-vascular endothelial growth factor) biologics have revolutionized the pharmacological management of chorioretinal diseases. However, the systemic adverse events such as stroke or bleeding are the concerns for many patients and physicians. The mechanism to develop these s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Quan-Yong, Chen, Li-Shuang, Shen, Yu, Liao, Yan-Hong, Wang, Yan-Yan, Yang, Jie, Jin, Yuanhui, Cheng, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668998/
https://www.ncbi.nlm.nih.gov/pubmed/34903819
http://dx.doi.org/10.1038/s41598-021-03335-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668998/
https://www.ncbi.nlm.nih.gov/pubmed/34903819
http://dx.doi.org/10.1038/s41598-021-03335-3

Ejemplares similares